Lung-transplant recipients

Clinical trials for Lung-transplant recipients explained in plain language.

Never miss a new study

Get alerted when new Lung-transplant recipients trials appear

Sign up with your email to follow new studies for Lung-transplant recipients, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New drug could slow lung decline in transplant patients

Disease control Completed

This phase 3 trial tests whether nintedanib, a drug already used for lung scarring, can slow the decline in lung function in lung transplant recipients who develop bronchiolitis obliterans syndrome (BOS), a form of chronic rejection. 58 participants received either nintedanib or …

Matched conditions: LUNG-TRANSPLANT RECIPIENTS

Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Jun 26, 2026 14:53 UTC

Lung-transplant recipients

Get alerted when new Lung-transplant recipients trials appear

New drug could slow lung decline in transplant patients